All Stories

  1. Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

    Article • Geburtshilfe und Frauenheilkunde, May 2016, Thieme Publishing Group

    Dr. med. Lennard L Schroeder